Fundraising FoxTelios Pharma
1 known investors
Find your way into Telios Pharma
Sign up to see every warm intro you have to Telios Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Telios Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Telios Pharma is a clinical-stage biopharmaceutical company developing first-in-class topical and oral BTK-inhibitor drugs targeting mast-cell-mediated inflammation, including TL-925 for dry eye disease.
Investors · 1
Frequently asked questions
- What does Telios Pharma do?
- Telios Pharma is a clinical-stage biopharmaceutical company developing first-in-class topical and oral BTK-inhibitor drugs targeting mast-cell-mediated inflammation, including TL-925 for dry eye disease.
- Who are Telios Pharma's investors?
- Telios Pharma's investors include SR One Capital Management.